Valeant Pharmaceuticals North America

Bausch Health Companies Inc., formerly known as Valeant Pharmaceuticals, is a global diversified pharmaceutical and medical device company headquartered in Laval, Canada. The company develops, manufactures, and markets a wide array of products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. Its core business is organized into several major segments, including Bausch + Lomb, Salix Pharmaceuticals, and Ortho Dermatologics. Bausch Health's portfolio includes well-known brands such as Xifaxan, Duobrii, and Lumify, alongside a significant presence in the contact lens and surgical eye care markets. Following a major corporate restructuring and rebranding in 2018, the company has focused on organic growth, debt reduction, and advancing its core pipeline assets. The company operates manufacturing and research facilities globally, serving patients in over 90 countries.